IP Library Granted Patent US 9,499,825
Granted Patent B2
US 9,499,825 · App. 13/556,100 · Granted Nov 22, 2016

Dual inducible system for the condensed single protein production system

Inventors: Masayori Inouye (New Brunswick, NJ); Lili Mao (Piscataway, NJ); S. Thangminlal Vaiphei (Highland Park, NJ); Yojiro Ishida (Highland Park, NJ)
Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
C12N15/70C12P21/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,499,825
App. No.
13/556,100
Granted
Nov 22, 2016
Kind
B2
Abstract

The present invention provides a dual inducible system for single protein production, as well as a method of inducing high level protein expression using amino acids.

Claims (12)

1. A system for expressing a single target protein in an E. coli cell comprising:

(i) an isolated E. coli tryptophan auxotroph; and

(ii) an expression vector comprising an isolated nucleic acid sequence encoding E. coli MazF protein with W14F and W83L substitutions, a sequence-specific mRNA endoribonuclease.

2. The system of claim 1 , further comprising an expression vector comprising an isolated nucleic acid sequence encoding a target protein.

3. The system of claim 1 , further comprising a composition suitable to induce the sequence-specific mRNA endoribonuclease.

4. The system of claim 2 further comprising a composition comprising tryptophan.

5. A system for expressing a single target protein in an E. coli cell comprising:

(i) an isolated E. coli histidine auxotroph; and

(ii) an expression vector comprising an isolated nucleic acid sequence encoding E. coli MazF protein with G27K and H28R substitutions, a sequence-specific mRNA endoribonuclease.

6. The system of claim 5 , further comprising an expression vector comprising an isolated nucleic acid sequence encoding a target protein.

7. The system of claim 5 , further comprising a composition suitable to induce the sequence-specific mRNA endoribonuclease.

8. The system of claim 7 , further comprising a composition comprising histidine.

Assignments (3)
CONFIRMATORY LICENSE Recorded Mar 8, 2022
From: RUTGERS, THE STATE UNIV. OF N.J.
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 059198/0235 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2014
From: THE UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
To: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
Reel/Frame 032950/0280 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 12, 2012
From: INOUYE, MASAYORI; MAO, LILI; VAIPHEI, S. THANGMINLAL; ISHIDA, YOJIRO
To: UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
Reel/Frame 029277/0948 →
Continuity (2)
Provisional Application 61510766 · Jul 22, 2011
Related Publication 20130029426A1 · Jan 31, 2013